Related Experiment Video
Updated: May 24, 2026

07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Animal models of peripheral neuropathies
1Departments of Neurology and Neuroscience, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, MD 21205, USA. ahoke@jhmi.edu
Summary
Animal models for peripheral neuropathies use diverse measures. Epidermal innervation via skin biopsy offers a promising, clinically relevant outcome measure for future therapeutic trials.
Area of Science:
- Neurology
- Pathology
- Biomedical Research
Background:
- Peripheral neuropathies are common neurological disorders with significant public health impact.
- Established animal models exist for diabetic, chemotherapy-induced, and HIV-associated neuropathies.
- Current models often employ pathological, electrophysiological, and behavioral assessments.
Purpose of the Study:
- To highlight a shift towards clinically relevant outcome measures in animal models of peripheral neuropathy.
- To introduce epidermal innervation assessment via skin biopsy as a novel outcome measure.
- To emphasize the need for validation of this method against established clinical assessments.
Main Methods:
- Review of outcome measures used in established animal models of peripheral neuropathy.
- Identification of epidermal innervation via skin biopsy as a translatable outcome measure.
- Discussion of the need for blinded, quantitative assessments.
Main Results:
- Animal models commonly utilize a range of outcome measures to study neuropathy pathogenesis.
- Epidermal innervation assessment using skin biopsy is emerging as a viable, quantitative outcome measure.
- This method aligns with clinical practices and allows for blinded evaluation.
Conclusions:
- Epidermal innervation assessment in skin biopsies represents a promising, clinically relevant outcome measure for peripheral neuropathy research.
- Further clinical trials are necessary to validate its translational utility.
- This method holds potential for future therapeutic drug development and clinical trials.

